0001104659-22-026879.txt : 20220224 0001104659-22-026879.hdr.sgml : 20220224 20220224212516 ACCESSION NUMBER: 0001104659-22-026879 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEC TIMOTHY C CENTRAL INDEX KEY: 0001194020 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 22674074 MAIL ADDRESS: STREET 1: C/O OPGEN, INC. STREET 2: 708 QUINCE ORCHARD ROAD, SUITE 205 CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm227622-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-02-22 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001194020 DEC TIMOTHY C C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 0 1 0 0 Senior Vice-President & CFO Employee Stock Option (Right to Buy) 32.20 2022-02-22 4 A 0 25000 0 A 2032-02-22 Common Stock 25000 25000 D Restricted Stock Units 2022-02-22 4 A 0 2000 0 A Common Stock 2000 2000 D The option vests in four equal annual installments beginning on February 22, 2023. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023. /s/ Timothy C. Dec 2022-02-24